Six new peptides recommended by PCAC to be allowed to be manufactured A GLP-1/glucagon dual agonist shows promise in reducing alcohol drinking A cochlear implant for blindness is approved in the EU for vision loss In a reversal, Sen Cassidy expresses support of Schwartz for CDC Director Tips & tricks for making a graphical abstract with AI - and my thoughts on it
Aroda reports institutional contracts from Amgen, Applied Therapeutics, AstraZeneca, Biomea, Boehringer Ingelheim, Corcept, Eli Lilly, Fractyl, Kailera, Novo Nordisk, Pfizer, Recordati, Rhythm and Servier, as well as consulting fees from Baim Institute for Clinical Research, Mediflix, Sanofi, and Roche
Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization
While offering these calls for broader coverage as part of a broad assessment of obesity management, ICER also urged companies to reduce the costs of weight-loss medicines
This extended period of efficacy stems from Dihexa's ability to modulate the expression levels of synapse-associated proteins (such as PSD-95, GluA1, etc.), rather than simply stimulating neuronal electrical activity
Activation of Nrf2 and a subsequent induction of GCL have been reported for various oxidants and electrophiles such as DEM, H 2 O 2 , quinones, 4-hydroxynonenal, methyl mercury, arsenicals, and plasmonic gold nanoparticles (Zhang et al